| Date Filed | Type | Description |
| 06/02/2023 |
4
| Simonian Nancy A (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 2,044 shares
@ $0 |
|
| 04/04/2023 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,852 shares
@ $2.58, valued at
$4.8k
Exercised 6,000 restricted stock units
@ $0 |
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 115,000 options to buy
@ $6.73, valued at
$774k
Granted 80,250 restricted stock units
@ $0 |
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 58,883 shares
@ $1.12, valued at
$65.9k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 304,000 options to buy
@ $11.41, valued at
$3.5M
|
|
| 12/21/2020 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Exercised 10,761 options to buy
@ $3.04, valued at
$32.7k
Exercised 14,168 options to buy
@ $8.51, valued at
$120.6k
Exercised 4,988 options to buy
@ $10.09, valued at
$50.3k
|
|
| 06/18/2020 |
4
| Simonian Nancy A (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 15,690 options to buy
@ $3.59, valued at
$56.3k
|
|
| 05/19/2020 |
4
| Simonian Nancy A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 1,335 shares
@ $0
Granted 3,171 options to buy
@ $160.33, valued at
$508.4k
|
|
| 02/14/2020 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 294,000 options to buy
@ $7.54, valued at
$2.2M
|
|
| 12/23/2019 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Exercised 33,429 options to buy
@ $3.04, valued at
$101.6k
Exercised 10,762 options to buy
@ $3.04, valued at
$32.7k
Exercised 8,210 options to buy
@ $3.04, valued at
$25k
|
|
| 06/13/2019 |
4
| Simonian Nancy A (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 15,690 options to buy
@ $7.07, valued at
$110.9k
|
|
| 05/22/2019 |
4
| Simonian Nancy A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 2,963 shares
@ $0
Granted 7,038 options to buy
@ $64.38, valued at
$453.1k
|
|
| 02/14/2019 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 188,000 shares
@ $0
Granted 285,000 options to buy
@ $6.71, valued at
$1.9M
|
|
| 12/03/2018 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Exercised 23,454 options to buy
@ $1.01, valued at
$23.7k
Exercised 75,050 options to buy
@ $1.01, valued at
$75.8k
Exercised 12,084 options to buy
@ $3.04, valued at
$36.7k
|
|
| 05/22/2018 |
4
| Simonian Nancy A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 3,700 shares
@ $0
Granted 9,260 options to buy
@ $56.77, valued at
$525.7k
|
|
| 05/10/2018 |
4
| Simonian Nancy A (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 31,380 options
@ $16, valued at
$502.1k
|
|
| 05/08/2018 |
3
| Simonian Nancy A (Director) has filed a Form 3 on Evelo Biosciences, Inc. |
| 02/21/2018 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 285,000 options to buy
@ $10.09, valued at
$2.9M
|
|
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2016 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 07/06/2016 |
4
| Simonian Nancy A (President and CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Simonian Nancy A (President & CEO) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/21/2012 |
4
| Simonian Nancy A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 25,000 options to buy
@ $20.04, valued at
$501k
|
|
| 03/21/2012 |
3
| Simonian Nancy A (Director) has filed a Form 3 on SEATTLE GENETICS INC /WA |
| 05/17/2010 |
4
| Simonian Nancy A (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 15,000 options to buy
@ $6.14, valued at
$92.1k
|
|
| 05/18/2009 |
4
| Simonian Nancy A (Director) has filed a Form 4 on ARQULE INC |